Medical Devices News and Research

RSS

TYRX enrolls 1000th patient in CITADEL/CENTURION AIGISRx Antibacterial Envelope studies

TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with cardiovascular implantable electronic devices (CIEDs), announced today that the 1000th patient has been enrolled into the CITADEL & CENTURION clinical studies evaluating the company's AIGISRx Antibacterial Envelope.

2 Apr 2012

AngioDynamics presents NanoKnife System clinical study results at SSO 2012

AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced presentations on NanoKnife System clinical experience were given at the Society of Surgical Oncology (SSO) 2012 conference that took place March 21-24, 2012, in Orlando, Fla.

2 Apr 2012

Encision completes private placement of 1,500,000 shares of common stock

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that it had completed a private placement of 1,500,000 shares of its common stock.

2 Apr 2012

Vasomedical reports record revenue of $23.49M for period ended December 31, 2011

Vasomedical, Inc., a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces its operating results for the seven months ended December 31, 2011.

31 Mar 2012

PLC Systems fourth quarter total revenues increase to $189,000

PLC Systems Inc., a company focused on innovative medical device technologies, today reported financial results for the three- and twelve month periods ended December 31, 2011.

31 Mar 2012

PLC receives Brazilian government approval to market RenalGuard System

PLC Systems Inc., a company focused on innovative medical device technologies, today announced that it had received approval from the Brazilian government to market its innovative RenalGuard System in that country.

31 Mar 2012

Health law continues to trigger salvos in Mass. Senate race

Sen. Scott Brown, R-Mass., and Democratic challenger Elizabeth Warren continue to spar over health policy issues. At the same time, Brown's election to the Senate could continue to impact the fate of the health law.

30 Mar 2012

Supreme Court arguments, upcoming ruling poses challenges for political parties, presidential hopefuls

For all of the fretting by liberals and the tea-leaf reading by legal analysts about the pointed questioning from the justices about the health law, there is but one certainty: There will be substantial political fallout no matter how the court rules.

30 Mar 2012

Sientra closes $65M Series C financing

Sientra, a privately-held medical device company focused on the aesthetic and plastic surgery markets, announced today that it closed on its $65 million Series C financing led by Abingworth and with participation by Clarus Ventures, OrbiMed Advisors and all other insiders.

29 Mar 2012

Many medical implants never tested for safety

A new investigation by Consumer Reports reveals that while tens of millions of American consumers live with medical devices implanted in their bodies, many of these implants have never been tested for safety and manufacturers are often required to do nothing more than file paperwork and pay a user fee before bringing their products to market.

29 Mar 2012

Smiths Medical initiates voluntary market withdrawal of CoZmonitor Blood Glucose Monitoring Systems

Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a U.S. and Canada, voluntary market withdrawal of CoZmonitor Blood Glucose Monitoring Systems. The FDA has been apprised of this action.

29 Mar 2012

Relievant Medsystems secures $30M in Series D equity financing

Relievant Medsystems, Inc., a privately held medical device company pioneering the therapeutic use of basivertebral nerve ablation for the treatment of chronic axial low back pain, announced today that it has secured $30 million in a Series D equity financing to advance and expand the Company's worldwide clinical development programs.

29 Mar 2012

AHF calls on FDA Commissioner Hamburg to step down

AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS organization, today called on Food and Drug Administration (FDA) Commissioner Margaret Hamburg to step down in response to the agency's gross mismanagement of new product reviews and a lack of transparency.

29 Mar 2012

Adjusting ventilator to keep breath size and lung pressures lower can reduce death from lung injury

Carefully adjusting mechanical ventilator settings in the intensive care unit to pump smaller breaths into very sick lungs can reduce the chances of dying by as much as 8 percent, according to a study by critical care experts at Johns Hopkins. Study participants were evaluated for two years after their acute lung injury.

28 Mar 2012

As court brings health overhaul into focus, politicians pounce

Rick Santorum picks up his criticism of Mitt Romney's efforts in Massachusetts, which set up mandatory health coverage, but the former governor continues to assail the federal plan.

28 Mar 2012

Nepstar fourth quarter revenue increases 4.9% to RMB658.0M

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2011.

28 Mar 2012

Brown University to host 'Materials by Design' conference

Last June, President Obama announced the Materials Genome Initiative, an ambitious effort to assist American companies to develop advanced materials at twice the speed as currently possible and at a fraction of the cost.

28 Mar 2012

Boston Scientific pledges $100,000 to SIR Foundation's Discovery Campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Boston Scientific, a global leader in medical devices for cardiovascular and peripheral interventions, pledged $100,000 and is a "Pioneer" level supporter.

28 Mar 2012

FDA publishes first-of-a-kind guidance for medical device manufacturers

The U.S. Food and Drug Administration today published a first-of-a-kind guidance for medical device manufacturers, describing how the benefits and risks of certain medical devices are considered during pre-market review.

28 Mar 2012

Sientra receives FDA approval for new silicone gel-filled breast implant

Today, the U.S. Food and Drug Administration approved a silicone gel-filled breast implant manufactured by Sientra Inc. to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age.

27 Mar 2012